Neurocrine Biosciences shares owned by Campbell & Co. Investment Adviser
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Campbell & Co. Investment Adviser
from 13F filings
Historical chart of Campbell & Co. Investment Adviser investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Campbell & Co. Investment Adviser
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.3M | 17k | 140.38 |
| 2024-09-30 | $1.8M | 16k | 115.22 |
| 2023-03-31 | $1.0M | 10k | 101.22 |
| 2022-12-31 | $489k | 4.1k | 119.44 |
| 2022-09-30 | $635k | 6.0k | 106.22 |
| 2020-09-30 | $772k | 8.0k | 96.15 |
| 2019-12-31 | $2.5M | 24k | 107.50 |
| 2018-12-31 | $246k | 3.1k | 78.97 |
More positions owned by Campbell & Co. Investment Adviser
View all positions for Campbell & Co. Investment Adviser